112 related articles for article (PubMed ID: 21566402)
1. [Trends of causative and antimicrobial resistant organisms among patients with hematological malignancies in Japan].
Ohmagari N
Rinsho Ketsueki; 2011 Apr; 52(4):177-81. PubMed ID: 21566402
[No Abstract] [Full Text] [Related]
2. Frequency of bacterial isolates and pattern of antimicrobial resistance in patients with hematological malignancies: A snapshot from tertiary cancer center.
Sengar M; Kelkar R; Jain H; Biswas S; Pawaskar P; Karpe A
Indian J Cancer; 2014; 51(4):456-8. PubMed ID: 26842160
[TBL] [Abstract][Full Text] [Related]
3. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
Nordmann P; Naas T; Fortineau N; Poirel L
Curr Opin Microbiol; 2007 Oct; 10(5):436-40. PubMed ID: 17765004
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
Biedenbach DJ; Bell JM; Sader HS; Fritsche TR; Jones RN; Turnidge JD
Int J Antimicrob Agents; 2007 Aug; 30(2):143-9. PubMed ID: 17531446
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and emerging resistance in bacterial bloodstream infections in patients with hematologic malignancies.
Kara Ö; Zarakolu P; Aşçioğlu S; Etgül S; Uz B; Büyükaşik Y; Akova M
Infect Dis (Lond); 2015; 47(10):686-93. PubMed ID: 26024284
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and effects on bowel and throat microflora of oral levofloxacin as antibacterial prophylaxis in neutropenic patients with haematological malignancies.
Timmers GJ; Dijstelbloem Y; Simoons-Smit AM; van Winkelhoff AJ; Touw DJ; Vandenbroucke-Grauls CM; Huijgens PC
Bone Marrow Transplant; 2004 Apr; 33(8):847-53. PubMed ID: 14755314
[TBL] [Abstract][Full Text] [Related]
7. Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies.
Chong Y; Yakushiji H; Ito Y; Kamimura T
Int J Infect Dis; 2010 Sep; 14 Suppl 3():e171-5. PubMed ID: 20471883
[TBL] [Abstract][Full Text] [Related]
8. [Activities of antimicrobial agents against 8,474 clinical isolates obtained from 37 medical institutions during 2000 in Japan].
Yamaguchi K; Ohno A; Kashitani F; Iwata M; Kanda M; Tsujio Y; Sugiyama T; Toyoshima S; Kato J; Watanabe N; Kaku M; Kanemitsu K; Kunishima H; Kawaguchi H; Okada J; Shimoyama N; Igari J; Oguri T; Kaimori M; Watanabe K; Kobayashi Y; Uchida H; Katayama Y; Sugimoto K; Tashiro H; Kanno H; Yasujima M; Itoh K; Suwabe A; Obata R; Okada M; Kobayashi S; Tsuzimura M; Itoh A; Sumitomo M; Taminato T; Negayama K; Baba H; Makino H; Murase M; Miyamoto H; Minakuchi K; Ishigo S; Takii M; Horii T; Ono J; Takata T; Yamanaka K; Hamazaki N; Tsutsui T; Okabe H; Tatewaki K; Moro K; Hiramatsu K; Saikawa T; Ichiyama S; Nagasawa Z; Aoki Y; Matsushima T; Niki Y; Hirakata Y; Kohno S; Kuwabara M; Nakagawa K; Kageoka T; Hongo T; Yamane N
Jpn J Antibiot; 2003 Oct; 56(5):341-64. PubMed ID: 14692376
[TBL] [Abstract][Full Text] [Related]
9. Temporal changes in bacterial resistance in German intensive care units, 2001-2003: data from the SARI (surveillance of antimicrobial use and antimicrobial resistance in intensive care units) project.
Meyer E; Schwab F; Jonas D; Ruden H; Gastmeier P; Daschner FD
J Hosp Infect; 2005 Aug; 60(4):348-52. PubMed ID: 15923060
[TBL] [Abstract][Full Text] [Related]
10. [Comparative studies on activities on antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2000). III. Secular changes in susceptibility].
Kumamoto Y; Tsukamoto T; Hirose T; Matsukawa M; Takahashi S; Kunishima Y; Fujime M; Fujita K; Ogihara M; Ishibashi K; Igari J; Shigeta S; Oguri T; Yamaguchi K; Matsumoto T; Kashitani F; Yoshida H; Imafuku Y; Murai M; Ooe H; Nishikawa M; Watanabe K; Kobayashi Y; Uchida H; Oka T; Kitamura M; Takano Y; Matsuoka Y; Matsuda S; Sato S; Furuhama T; Kumon H; Monden K; Kohno S; Miyazaki Y; Tomono K; Aoki S; Mochida C; Hirakata Y
Jpn J Antibiot; 2002 Oct; 55(5):568-655. PubMed ID: 12532638
[TBL] [Abstract][Full Text] [Related]
11. Surveillance of antimicrobial susceptibility among bacterial isolates from intensive care unit patients of a tertiary-care university hospital in Iran: 2006-2009.
Mohammadtaheri Z; Pourpaki M; Mohammadi F; Namdar R; Masjedi MR
Chemotherapy; 2010; 56(6):478-84. PubMed ID: 21099220
[TBL] [Abstract][Full Text] [Related]
12. [A consideration on the results of nationwide surveillance of antimicrobial susceptibilities--gram-positive cocci and gram-negative cocci].
Kuroyama M; Okamoto E; Yago K
Jpn J Antibiot; 1998 Dec; 51(12):764-78. PubMed ID: 10077775
[TBL] [Abstract][Full Text] [Related]
13. [Etiologic agents and risk factors in nosocomial urinary tract infections].
Akkoyun S; Kuloğlu F; Tokuç B
Mikrobiyol Bul; 2008 Apr; 42(2):245-54. PubMed ID: 18697422
[TBL] [Abstract][Full Text] [Related]
14. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004.
Paul M; Gafter-Gvili A; Leibovici L; Bishara J; Levy I; Yaniv I; Shalit I; Samra Z; Pitlik S; Konigsberger H; Weinberger M
Isr Med Assoc J; 2007 Jun; 9(6):424-9. PubMed ID: 17642387
[TBL] [Abstract][Full Text] [Related]
15. Associated antimicrobial resistance in Escherichia coli, Pseudomonas aeruginosa, Staphylococcus aureus, Streptococcus pneumoniae and Streptococcus pyogenes.
Wimmerstedt A; Kahlmeter G
Clin Microbiol Infect; 2008 Apr; 14(4):315-21. PubMed ID: 18261127
[TBL] [Abstract][Full Text] [Related]
16. [Surveillance on gram-positive bacteria isolated from patients with hospital acquired infections or community acquired infections].
Li JT; Li Y; Wang J;
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):365-74. PubMed ID: 12820911
[TBL] [Abstract][Full Text] [Related]
17. Recent increase in enterococci, viridans streptococci, Pseudomonas spp. and multiresistant strains among haematological patients, with a negative impact on outcome. Results of a 3-year surveillance study at a single institution.
Cattaneo C; Casari S; Bracchi F; Signorini L; Ravizzola G; Borlenghi E; Re A; Manca N; Carosi G; Rossi G
Scand J Infect Dis; 2010 May; 42(5):324-32. PubMed ID: 20100118
[TBL] [Abstract][Full Text] [Related]
18. Activity of daptomycin against multi-resistant Gram-positive bacteria including enterococci and Staphylococcus aureus resistant to linezolid.
Johnson AP; Mushtaq S; Warner M; Livermore DM
Int J Antimicrob Agents; 2004 Oct; 24(4):315-9. PubMed ID: 15380254
[TBL] [Abstract][Full Text] [Related]
19. Current challenges in antibiotic resistance.
Hand WL
Adolesc Med; 2000 Jun; 11(2):427-38. PubMed ID: 10916132
[TBL] [Abstract][Full Text] [Related]
20. Assessment of the antibacterial activity of selected flavonoids and consideration of discrepancies between previous reports.
Cushnie TP; Hamilton VE; Lamb AJ
Microbiol Res; 2003; 158(4):281-9. PubMed ID: 14717448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
